209 related articles for article (PubMed ID: 19194545)
41. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P
Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175
[TBL] [Abstract][Full Text] [Related]
42. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K
Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803
[TBL] [Abstract][Full Text] [Related]
43. Management of sensitized pediatric patients prior to renal transplantation.
Pirojsakul K; Desai D; Lacelle C; Seikaly MG
Pediatr Nephrol; 2016 Oct; 31(10):1691-8. PubMed ID: 26801944
[TBL] [Abstract][Full Text] [Related]
44. Impact of rituximab therapy for treatment of acute humoral rejection.
Kaposztas Z; Podder H; Mauiyyedi S; Illoh O; Kerman R; Reyes M; Pollard V; Kahan BD
Clin Transplant; 2009; 23(1):63-73. PubMed ID: 19200217
[TBL] [Abstract][Full Text] [Related]
45. A modified perioperative regimen for deceased donor kidney transplantation in presensitized recipients without prior desensitization therapy.
Guo Z; Zhao D; Sa R; Wang L; Li S; Zhao G; Zhu L; Chen G
Front Immunol; 2023; 14():1223567. PubMed ID: 37475867
[TBL] [Abstract][Full Text] [Related]
46. Outcomes of Highly Sensitized Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Single-Center Experience With Desensitization.
Steggerda JA; Kang A; Pan SH; Sundaram V; Nissen NN; Klein AS; Todo T; Annamalai A; Vo A; Jordan SC; Kim IK
Transplant Proc; 2017; 49(6):1394-1401. PubMed ID: 28736013
[TBL] [Abstract][Full Text] [Related]
47. High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis.
Tanriover B; Wright SE; Foster SV; Roush KS; Castillo-Lugo JA; Fa K; Levy FL; Mejia A
Transplant Proc; 2008 Dec; 40(10):3393-6. PubMed ID: 19100397
[TBL] [Abstract][Full Text] [Related]
48. Desensitization and renal transplant: plasmapheresis/IVIG standard dose in patients with high immunological risk.
Flores-Gama F; Mondragón-Ramírez GA; Bochicchio-Riccardelli T
Cir Cir; 2009; 77(5):369-74. PubMed ID: 19944025
[TBL] [Abstract][Full Text] [Related]
49. Use of high-dose human immune globulin in highly sensitized patients on the kidney transplant waiting list: one center's experience.
Gozdowska J; Urbanowicz A; Perkowska-Ptasinska A; Michalska K; Chmura A; Szmidt J; Durlik M
Transplant Proc; 2009 Oct; 41(8):2997-3001. PubMed ID: 19857660
[TBL] [Abstract][Full Text] [Related]
50. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC
Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic Effect of Plasmapheresis and Intravenous Immunoglobulin in Recipients of Kidney Transplant With High Panel-reactive Antibody Levels: A Single-center Experience.
Sendogan DO; Saritas H; Kumru G; Erdogmus S; Tuzuner A; Keven K; Sengul S
Transplant Proc; 2019 Sep; 51(7):2254-2256. PubMed ID: 31474291
[TBL] [Abstract][Full Text] [Related]
52. Desensitization Regimen Consisting of High-Dose Intravenous Immunoglobulin, Plasmapheresis, and Rituximab (an Anti-CD20 Antibody), Without Eculizumab and/or Bortezomib, in 41 Highly Sensitized Kidney Transplant Recipients.
Ishida H; Unagami K; Omoto K; Kanzawa T; Tanabe K
Exp Clin Transplant; 2021 Oct; 19(10):1032-1040. PubMed ID: 34498551
[TBL] [Abstract][Full Text] [Related]
53. Early and late humoral rejection: a clinicopathologic entity in two times.
Péfaur J; Díaz P; Panace R; Salinas P; Fiabane A; Quinteros N; Chea R; Naranjo E; Wurgaft A; Beltran E; Elgueta S; Wegmann ME; Gajardo JG; Contreras L
Transplant Proc; 2008 Nov; 40(9):3229-36. PubMed ID: 19010241
[TBL] [Abstract][Full Text] [Related]
54. Clinical characteristics of 15 cases of renal transplantation with pre
Fan H; Liu J; Sun J; Wang J; Pang X; Shang W; Feng G; Li J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1583-1591. PubMed ID: 38432887
[TBL] [Abstract][Full Text] [Related]
55. Repeated cycles of high-dose intravenous immunoglobulin and plasmapheresis for treatment of late antibody-mediated rejection of renal transplants.
Lee CY; Lin WC; Wu MS; Yang CY; Yeh CC; Tsai MK
J Formos Med Assoc; 2016 Oct; 115(10):845-852. PubMed ID: 27542515
[TBL] [Abstract][Full Text] [Related]
56. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N
Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198
[TBL] [Abstract][Full Text] [Related]
57. Post-transplant Desensitization for Deceased Donor Kidney Transplant Recipients: A Single Center Experience.
Kumar D; Fattah H; Kimball PM; LeCorchick S; McDougan FA; King AL; Gupta G
Clin Transpl; 2016; 32():143-151. PubMed ID: 28564532
[TBL] [Abstract][Full Text] [Related]
58. Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation.
Jeong JC; Jambaldorj E; Kwon HY; Kim MG; Im HJ; Jeon HJ; In JW; Han M; Koo TY; Chung J; Song EY; Ahn C; Yang J
Medicine (Baltimore); 2016 Feb; 95(5):e2635. PubMed ID: 26844479
[TBL] [Abstract][Full Text] [Related]
59. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report.
Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H
Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279
[TBL] [Abstract][Full Text] [Related]
60. Desensitization protocol for highly sensitized renal transplant patients: a single-center experience.
Kute VB; Vanikar AV; Trivedi HL; Shah PR; Goplani KR; Patel HV; Gumber MR; Patel RD; Kanodia KV; Suthar KS; Trivedi VB; Modi PR
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):662-9. PubMed ID: 21743208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
